| RS1565939303 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565939337 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565939532 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565940214 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565940240 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565940841 |
TBX5
|
Health Risk |
Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565940856 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565940860 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565940930 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565941003 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565941046 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1565941072 |
TBX5
|
Health Risk |
Likely pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1565941245 |
LATS2
|
Health Risk |
Likely pathogenic |
Malignant peritoneal mesothelioma, Malignant peritoneal mesothelioma |
| RS1565941422 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565941434 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565941529 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565941576 |
TBX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Holt-Oram syndrome, Cardiovascular phenotype |
| RS1565941579 |
TBX5
|
Health Risk |
Likely pathogenic |
6 conditions, Holt-Oram syndrome |
| RS1565941587 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565942358 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4H |
| RS1565942511 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Aortic valve disease 2 |
| RS1565943228 |
MYBPC1
|
Health Risk |
Pathogenic |
MYBPC1-related disorder, Myopathy |
| RS1565943262 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1565943328 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1565945249 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565946117 |
CNTN1
|
Health Risk |
Pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS1565956310 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565960909 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565961210 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565961371 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1565962725 |
SYT1
|
Health Risk |
Pathogenic |
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome, SYT1-associated neurodevelopmental disorder |
| RS1565964707 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565965603 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565971583 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565971720 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565972026 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS1565973030 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565973210 |
POLE
|
Health Risk |
Likely pathogenic |
Colorectal carcinoma, Colorectal carcinoma |
| RS1565973352 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS1565975090 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565975328 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS1565977663 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565977796 |
CDK8
|
Health Risk |
Likely pathogenic |
7 conditions, Intellectual developmental disorder with hypotonia and behavioral abnormalities |
| RS1565978171 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565979631 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS1565979764 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565980363 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gastric cancer |
| RS1565981137 |
MED13L
|
Health Risk |
Pathogenic/Likely pathogenic |
Dextro-looped transposition of the great arteries, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1565981538 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565981653 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565981717 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1565981775 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1565982697 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1565985681 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1565986506 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1565986587 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Intrauterine growth retardation |
| RS1565987758 |
MED13L
|
Health Risk |
Pathogenic |
Dextro-looped transposition of the great arteries, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1565993028 |
MED13L
|
Health Risk |
Likely pathogenic |
MED13L-related disorder, MED13L-related disorder |
| RS1565995034 |
MED13L
|
Health Risk |
Pathogenic |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1565995054 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1565995146 |
MED13L
|
Health Risk |
Likely pathogenic |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1565997261 |
MED13L
|
Health Risk |
Pathogenic |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1566003392 |
TCTN1
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS1566005476 |
MED13L
|
Health Risk |
Pathogenic |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1566007803 |
MED13L
|
Health Risk |
Conflicting classifications of pathogenicity |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1566009282 |
IGF1
|
Health Risk |
Likely pathogenic |
— |
| RS1566010195 |
MED13L
|
Health Risk |
Likely pathogenic |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1566011034 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1566011496 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1566014158 |
MED13L
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1566025668 |
PDX1
|
Health Risk |
Likely pathogenic |
— |
| RS1566025744 |
PDX1
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 4, Maturity-onset diabetes of the young type 4 |
| RS1566039159 |
ALDH18A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1566055368 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1566058677 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1566059895 |
SACS
|
Health Risk |
Likely pathogenic |
— |
| RS1566067386 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS1566067485 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1566067709 |
CHST11
|
Health Risk |
Conflicting classifications of pathogenicity |
Chondrodysplasia, clino-symphalangism |
| RS1566068552 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1566069517 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1566072001 |
SACS
|
Health Risk |
Pathogenic |
— |
| RS1566073911 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1566074689 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1566074908 |
TCTN3
|
Health Risk |
Likely pathogenic |
Orofacial-digital syndrome IV, Joubert syndrome 18 |
| RS1566075180 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1566078009 |
UBE3B
|
Health Risk |
Pathogenic |
Oculocerebrofacial syndrome, Kaufman type |
| RS1566078120 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1566079629 |
HECTD4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures, spasticity |
| RS1566091706 |
SUCLA2
|
Health Risk |
Likely pathogenic |
— |
| RS1566092307 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1566092362 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS1566092470 |
HNF1A
|
Health Risk |
Pathogenic |
Type 1 diabetes mellitus 20, Monogenic diabetes |
| RS1566121215 |
SLC25A15
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1566123619 |
SLC25A15
|
Health Risk |
Pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1566132205 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS1566133616 |
FREM2
|
Health Risk |
Pathogenic |
Isolated cryptophthalmia, Isolated cryptophthalmia |
| RS1566137903 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS1566147222 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Porokeratosis 3 |
| RS1566147422 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 10 |